Description
Chloroquine Tablets
• Product Overview
Chloroquine Tablets are antimalarial medicines belonging to the 4-aminoquinoline class. They are used for the treatment and prevention of malaria caused by chloroquine-sensitive Plasmodium species. Chloroquine is also prescribed for certain autoimmune conditions, such as rheumatoid arthritis and systemic lupus erythematosus (SLE), under medical supervision. The medicine works by interfering with the growth and survival of malaria parasites within red blood cells.
• Available Strengths
– Chloroquine 250 mg Tablets
– Chloroquine 500 mg Tablets
• Therapeutic Category
Antimalarial Agent / Disease-Modifying Antirheumatic Drug (DMARD)
• Indications
Chloroquine Tablets are indicated for:
– Treatment of Chloroquine-Sensitive Malaria
– Malaria Prophylaxis (Prevention) in Appropriate Regions
– Extraintestinal Amebiasis (as prescribed)
– Rheumatoid Arthritis
– Systemic Lupus Erythematosus (SLE)
– Other Indications as Directed by a Healthcare Professional
• Common Side Effects
Some patients may experience:
– Nausea
– Vomiting
– Abdominal discomfort
– Headache
– Dizziness
– Loss of appetite
– Blurred vision
• Serious Side Effects
Seek immediate medical attention if any of the following occur:
– Severe allergic reactions (Anaphylaxis)
– Retinal damage or vision changes with long-term use
– Irregular heartbeat or QT prolongation
– Severe hypoglycemia
– Muscle weakness
– Severe skin reactions
– Blood disorders
• Precautions
– Use only under the supervision of a qualified healthcare professional.
– Use only where chloroquine remains effective according to local malaria resistance patterns.
– Regular eye examinations are recommended during long-term therapy.
– Use cautiously in patients with liver disease, kidney disease, heart disease, psoriasis, or epilepsy.
– Inform your healthcare provider about all medicines being taken.
– Store below 30°C in a cool, dry place away from moisture and direct sunlight.
• Technical Information
• Active Ingredient
Chloroquine Phosphate
• Mechanism of Action
Chloroquine accumulates within malaria parasites and inhibits the detoxification of heme, leading to parasite death. In autoimmune diseases, it also exerts immunomodulatory effects by reducing inflammatory responses.
• Dosage Form
Tablet
• Route of Administration
Oral
• Shelf Life
24–36 Months (depending on packaging and regulatory requirements)
• Storage Conditions
Store below 30°C in a dry place protected from moisture and direct sunlight.
• Product Specifications
Product Name:- Chloroquine Tablets
Generic Name:- Chloroquine Phosphate
Strengths:- 250 mg, 500 mg
Dosage Form:- Tablet
Category:- Antimalarial / DMARD
Packaging:- Blister / Alu-Alu / Customized Export Packing
Shelf Life:- 24–36 Months
Storage:- Below 30°C
Origin:- India
• Regulatory Status & Supply Information
– Manufactured in WHO-GMP compliant facilities.
– Available for international export markets.
– Export documentation support available.
– Private Label Manufacturing available.
– Third-Party Manufacturing available.
– Customized export packaging available.
– Bulk quantities available for distributors, wholesalers, hospitals, NGOs, pharmacies, and government tenders.
• Who Should Source This Product?
This product is ideal for:
– Pharmaceutical Importers
– Pharmaceutical Distributors
– Government Procurement Agencies
– Hospital Procurement Companies
– NGOs & Global Health Organizations
– Pharmacy Chains
– International Tender Suppliers
– Private Label Brands
• Why Source From Mediora Exports?
– Trusted Pharmaceutical Exporter from India
– WHO-GMP Manufacturing Partners
– Competitive International Pricing
– Wide Product Portfolio
– Reliable Global Supply Chain
– Flexible Packaging Options
– Timely Delivery
– Complete Export Documentation Support
– Dedicated Export Support Team
• Contact Details
Mediora Exports
📧 Email: info@medioraexports.com
📱 Phone/WhatsApp: +91 99047 64844
For product inquiries, quotations, distributorship opportunities, private labeling, and bulk export orders, please contact our team.

Reviews
There are no reviews yet.